Updated resource: unpicking the COVID-19 extremely vulnerable category for people affected by cancer

Latest from the Blog

Discussing impotence with patients

Discussing impotence with patients

Friday 19th June 2020 For many patients, the relief of surviving their treatment or managing their condition can be followed with questions about other aspects of their life. Impotence can be very common after treatment for colorectal cancer; often affecting up to 90%...

read more

Related Posts

Infection prevention for cancer patients

Infection prevention for cancer patients

Friday 6th March 2020 With COVID-19 hitting the headlines this week, the public are being advised to take infection prevention measures, such as thorough hand washing and covering coughs and sneezes. People affected by cancer, especially certain types such as...

read more

Wednesday 15th April 2020

People with certain cancers and those who have received or are receiving certain treatments are at risk of severe illness if they catch coronavirus (COVID-19). One Cancer Voice charities (in partnership with NHS England) have confirmed this includes:

  • Every patient undergoing active chemotherapy
  • Patients who have received chemotherapy in the last three months (advise patients to contact their care team to discuss their specific circumstances. In the meantime, patients should follow the Public Health England guidance on ‘shielding’ – in summary, stay at home and avoid face-to-face contact for a period of 12 weeks)
  • Patients with blood disorders who are immunocompromised but not receiving chemotherapy
  • Patients having radiotherapy for metastatic lung tumours
  • Patients with metastatic cancer in the lungs who are not currently receiving treatment (if they have not received a letter, advise patients to contact their care team to discuss their specific circumstances. In the meantime, patients should follow the Public Health England guidance on ‘shielding’ – in summary, stay at home and avoid face-to-face contact for a period of 12 weeks)
  • Patients having any targeted treatments (more than just antibody treatments) and anti-angiogenesis targeted drugs
  • Transplant patients (if they have had a transplant within the last 6 months, and if they are taking any immunosuppression)
  • Patients with a rare disease and that disease significantly increases their risk of infection

Find out more:

LinkedIn | Twitter | Facebook

Latest from the Blog

Discussing impotence with patients

Discussing impotence with patients

Friday 19th June 2020 For many patients, the relief of surviving their treatment or managing their condition can be followed with questions about other aspects of their life. Impotence can be very common after treatment for colorectal cancer; often affecting up to 90%...

read more

Related Posts

Infection prevention for cancer patients

Infection prevention for cancer patients

Friday 6th March 2020 With COVID-19 hitting the headlines this week, the public are being advised to take infection prevention measures, such as thorough hand washing and covering coughs and sneezes. People affected by cancer, especially certain types such as...

read more